A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.

Source:http://linkedlifedata.com/resource/pubmed/id/10929027

Download in:

View as

General Info

PMID
10929027